NexgenRx Announces Declaration of Dividend

3 years ago

TORONTO, ON / ACCESSWIRE / January 20, 2022 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that…

Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates

3 years ago

HACKENSACK, NJ / ACCESSWIRE / January 20, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is…

Jupiter Wellness’ Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market

3 years ago

Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti TherapeuticsBenuvia has begun focusing on Psilocybin, DMT, and MDMA.Benuvia's…

Clairvoyant Therapeutics Receives Approval in Canada to Initiate a World-leading Psilocybin Trial for Treatment of Alcohol Use Disorder

3 years ago

VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Clairvoyant Therapeutics, a Canadian biotech company focused on the development of…

Goodbody Health (Previously Sativa Wellness Group) Announces a New Sponsorship Agreement With James Hedley

3 years ago

VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased…

Icario Celebrates Year of Record Growth and Impact

3 years ago

Strong Company Momentum Advances Icario’s Mission of Making the World a Healthier PlaceMINNEAPOLIS, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Icario,…

Revelation Biosciences Inc. Announces First Group of Patients Dosed in Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx-99 for the Prevention of H3N2 Influenza Infection

3 years ago

Top-line data anticipated in the second quarter of 2022SAN DIEGO, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ:…

Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Combination of Elzovantinib and Aumolertinib in EGFR Mutant Met-Amplified Non-Small Cell Lung Cancer

3 years ago

SAN DIEGO, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation…

Vallon Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

3 years ago

– Live video webcast presentation on Tuesday, January 25that 9:00 AM ET PHILADELPHIA, PA, Jan. 20, 2022 (GLOBE NEWSWIRE) --…

Healthcare Triangle, Inc. Releases Shareholder Update

3 years ago

Highlights Market Opportunity and Recent Accretive Acquisition Awarded Top 100 Premier Partner Status at Amazon World Services & Premier Partner Status…